Deroy & Devereaux Private Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Deroy & Devereaux Private Investment Counsel's BMY Position: Q4 2023 in Review
Deroy & Devereaux Private Investment Counsel sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 4,170 shares — an estimated $242K sold.
Deroy & Devereaux Private Investment Counsel first reported a position in BMY in Q1 2020 and held it in 15 quarters. The position peaked at $18.4M in Q2 2022. 2,365 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- Deroy & Devereaux Private Investment Counsel reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
- Deroy & Devereaux Private Investment Counsel sold 4,170 Bristol-Myers Squibb shares in Q4 2023, an estimated $242K.
- Deroy & Devereaux Private Investment Counsel first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 15 quarters.
- Deroy & Devereaux Private Investment Counsel's Bristol-Myers Squibb position peaked at $18.4M in Q2 2022.
- 2,365 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q4 2023, filed 29 Jan 2024.